Bloodstream infections in critically ill patients: an expert statement
Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic
signs of infection and may be either secondary to a documented source or primary—that is …
signs of infection and may be either secondary to a documented source or primary—that is …
Timing of antibiotic therapy in the ICU
Severe or life threatening infections are common among patients in the intensive care unit
(ICU). Most infections in the ICU are bacterial or fungal in origin and require antimicrobial …
(ICU). Most infections in the ICU are bacterial or fungal in origin and require antimicrobial …
Rationalizing antimicrobial therapy in the ICU: a narrative review
The massive consumption of antibiotics in the ICU is responsible for substantial ecological
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …
Management strategies for severe Pseudomonas aeruginosa infections
H Do Rego, JF Timsit - Current Opinion in Infectious Diseases, 2023 - journals.lww.com
Carbapenem resistance in difficult-to-treat P. aeruginosa (DTR-PA) strains is primarily
mediated by loss or reduction of the OprD porin, overexpression of the cephalosporinase …
mediated by loss or reduction of the OprD porin, overexpression of the cephalosporinase …
A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients
AJ Heffernan, SMS Lim, J Lipman… - Anaesthesia Critical Care & …, 2021 - Elsevier
Critically ill patients admitted to intensive care unit (ICU) with severe infections, or those who
develop nosocomial infections, have poor outcomes with substantial morbidity and mortality …
develop nosocomial infections, have poor outcomes with substantial morbidity and mortality …
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective …
A Vena, M Schenone, S Corcione… - Journal of …, 2024 - academic.oup.com
Objectives To determine the association of adequate empirical combination therapy (AECT)
with 30-day all-cause mortality in patients with septic shock due to Pseudomonas …
with 30-day all-cause mortality in patients with septic shock due to Pseudomonas …
Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram …
F Barbier, C Dupuis, N Buetti, C Schwebel, É Azoulay… - Critical Care, 2024 - Springer
Key messages In this study including 391 critically ill patients with nosocomial pneumonia
due to Gram-negative pathogens, combination therapy was not associated with a reduced …
due to Gram-negative pathogens, combination therapy was not associated with a reduced …
Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to Pseudomonas aeruginosa: A meta-analysis
L Onorato, M Macera, F Calò, P Cirillo… - International Journal of …, 2022 - Elsevier
Objectives To compare the clinical and microbiological outcomes of patients treated with
beta-lactam monotherapy or combination therapy for Pseudomonas aeruginosa infections …
beta-lactam monotherapy or combination therapy for Pseudomonas aeruginosa infections …
Evaluating mono-and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model
ML Avent, KL McCarthy, FB Sime, S Naicker… - Microbiology …, 2022 - Am Soc Microbiol
Debate continues as to the role of combination antibiotic therapy for the management of
Pseudomonas aeruginosa infections. We studied the extent of bacterial killing by and the …
Pseudomonas aeruginosa infections. We studied the extent of bacterial killing by and the …
β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis
AJ Heffernan, FB Sime, J Sun, J Lipman… - International journal of …, 2020 - Elsevier
Background Combining aminoglycosides with β-lactam antibiotics for treating serious
infections has not been associated with reduced mortality in previous meta-analyses …
infections has not been associated with reduced mortality in previous meta-analyses …